Literature DB >> 18271681

Is A163G polymorphism in the osteoprotegerin gene associated with heel velocity of sound in postmenopausal women?

K Zajíčková1, A Zemanová, M Hill, I Žofková.   

Abstract

Osteoprotegerin (OPG) plays an important inhibitory role in osteoclastogenesis. Polymorphisms in the OPG gene recently have been associated with various bone phenotypes including fractures. The aim of the present study was to investigate the association between three informative OPG polymorphisms and quantitative ultrasound variables of the heel. In a cohort of 165 perimenopausal women polymorphisms in the OPG promoter (A163G, T245G) and in exon 1 (G1181C) were assessed by PCR-RFLP analysis. The distribution of the investigated genotypes was similar to other Caucasian women (A163G-AA 68 %, AG 30 %, GG 2 %, T245G-TT 84.4 %, TG 15 %, GG 0.6 %, G1181C- GG 22 %, CG 55 %, CC 23 %). After adjustment for body mass index and years since menopause, in a subgroup of 87 postmenopausal subjects, calcaneal velocity of sound (VOS, m/s) was significantly associated with A163G polymorphism (p=0.0102, ANCOVA). Women with the presence of G allele (AG+GG genotypes) had significantly lower VOS than women with AA genotype. Neither T245G nor G1181C were associated with calcaneal ultrasound indices. In conclusion, A163G polymorphism was significantly associated with VOS at the heel in a limited cohort of postmenopausal women. The present study replicated in part the previous findings about OPG gene variations and peripheral bone mass in Caucasian women.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18271681     DOI: 10.33549/physiolres.931500

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  7 in total

Review 1.  Molecular genetic studies of gene identification for osteoporosis: the 2009 update.

Authors:  Xiang-Hong Xu; Shan-Shan Dong; Yan Guo; Tie-Lin Yang; Shu-Feng Lei; Christopher J Papasian; Ming Zhao; Hong-Wen Deng
Journal:  Endocr Rev       Date:  2010-03-31       Impact factor: 19.871

2.  Relationship between A163G osteoprotegerin gene polymorphism and other osteoporosis parameters in Roma and non-Roma postmenopausal women in eastern Slovakia.

Authors:  Marta Mydlárová Blaščáková; Ľudmila Blaščáková; Janka Poráčová; Jozef Mydlár; Janka Vašková; Jarmila Bernasovská; Iveta Boroňová; Eva Petrejčíková; Ivan Bernasovský
Journal:  J Clin Lab Anal       Date:  2016-11-15       Impact factor: 2.352

3.  Associations between osteoprotegerin polymorphisms and bone mineral density: a meta-analysis.

Authors:  Young Ho Lee; Jin-Hyun Woo; Seong Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Mol Biol Rep       Date:  2009-07-30       Impact factor: 2.316

Review 4.  Genetics of osteoporosis: accelerating pace in gene identification and validation.

Authors:  Wen-Feng Li; Shu-Xun Hou; Bin Yu; Meng-Meng Li; Claude Férec; Jian-Min Chen
Journal:  Hum Genet       Date:  2009-12-12       Impact factor: 4.132

5.  Osteoprotegerin Polymorphisms in a Mexican Population with Rheumatoid Arthritis and Generalized Osteoporosis: A Preliminary Report.

Authors:  Maria Guadalupe Zavala-Cerna; Maria Cristina Moran-Moguel; Jesus Alejandro Cornejo-Toledo; Norma Guadalupe Gonzalez-Montoya; Jose Sanchez-Corona; Mario Salazar-Paramo; Arnulfo Hernan Nava-Zavala; Erika Anita Aguilar-Chavez; Miriam Fabiola Alcaraz-Lopez; Alicia Guadalupe Gonzalez-Sanchez; Laura Gonzalez-Lopez; Jorge Ivan Gamez-Nava
Journal:  J Immunol Res       Date:  2015-05-03       Impact factor: 4.818

6.  Osteoporosis and polymorphisms of osteoprotegerin gene in postmenopausal women - a pilot study.

Authors:  Selma Cvijetic; Simeon Grazio; Pasezada Kosovic; Melita Uremovic; Tomislav Nemcic; Jasminka Bobic
Journal:  Reumatologia       Date:  2016-03-24

7.  Genetic polymorphism of the OPG gene associated with breast cancer.

Authors:  Jasmin Teresa Ney; Ingolf Juhasz-Boess; Frank Gruenhage; Stefan Graeber; Rainer Maria Bohle; Michael Pfreundschuh; Erich Franz Solomayer; Gunter Assmann
Journal:  BMC Cancer       Date:  2013-01-31       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.